Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Milrinone

78415-72-2C12H9N3O211.224 g/mol

A member of the class of bipyridines that is 2-pyridone which is substituted at positions 3, 5, and 6 by cyano, pyrid-4-yl, and methyl groups, respectively. It is used (particularly intravenously, as the lactate) for the short-term management of severe heart failure. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number78415-72-2ChEBI ↗
Molecular formulaC12H9N3OChEBI ↗
Molar mass211.224 g/molChEBI ↗
Monoisotopic mass211.07456 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:50693ChEBI ↗

Cross-source molecular data

PubChem
Molar mass211.22 g/molPubChem ↗
Exact mass211.074561919 DaPubChem ↗
Computed XLogP0PubChem ↗
Topological polar surface area (Ų)65.8PubChem ↗
H-bond donors1PubChem ↗
H-bond acceptors3PubChem ↗
Rotatable bonds1PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
milrinone
2-methyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile
PZRHRDRVRGEVNW-UHFFFAOYSA-N
Cc1nc(=O)c(C#N)cc1-c1ccncc1
InChI=1S/C12H9N3O/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8/h2-6H,1H3,(H,15,16)

Names & synonyms

2-methyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrilemilrinonamilrinonum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

cardiovascular drugvasodilator agentantihypertensive agentcardiotonic drugplatelet aggregation inhibitorEC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitorantispasmodic drug

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00473431 mol

Uses 211.224 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 12 atoms
68.24%
N
Nitrogen · 3 atoms
19.89%
O
Oxygen · 1 atom
7.57%
H
Hydrogen · 9 atoms
4.29%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
BE886336 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US4313951 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US4413127 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:50693

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 4197 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.